Ads
related to: checkpoint inhibitors
Search results
Anti-Cancer Drug Pembrolizumab: Frequently Used Alone Or With Other Treatments
Forbes· 16 hours agoPembrolizumab, sold as Keytruda by Merck & Co., was one of the first inhibitors to hit the market. A...
Immune-checkpoint inhibitors protect bone by promoting osteogenesis, exploratory study shows
Medical Xpress· 5 days agoImmune checkpoint inhibitors (ICIs), widely employed anticancer agents, have been found to impact...
EpicentRx Announces Oral Presentation for the Most Clinically Advanced TGF-β Ligand Trap, AdAPT-001,...
Lodi News-Sentinel· 4 days ago...Conley, an MD Anderson Cancer Center (MDACC) Sarcoma Specialist and Lead PI, to give an oral presentation on the unprecedented clinical activity of AdAPT-001 plus an immune checkpoint inhibitor (ICI) in the ongoing Phase 2 open-label BETA PRIME clinical trial that has so far enrolled close to 70...
Advances in melanoma treatment saved this Lansdale man's life and changed his outlook
PhillyVoice.com· 14 hours agoSchuster, now 26, had surgery to remove the growth above his ankle, causing a deep wound that...
Immunotherapy for stomach cancer: Types and effectiveness
Medical News Today· 5 days agoImmunotherapy may help shrink a tumor or slow the growth of cancer cells. People may have it in...
Small Business - Shelby County Reporter | Shelby County Reporter
The Shelby County Reporter· 4 days agoPreliminary data from CLN-619 in combination with checkpoint inhibitor pembrolizumab show objective responses in patients with tumor types that are typically ...
OncoHost to Present Poster Demonstrating PROphet®'s Application in Multiple Cancer Indications at...
FOX21 Colorado Springs· 4 days agoThe presentation will highlight the ability of the company's PROphet® platform to predict clinical benefit from immune checkpoint inhibitor (ICI)-based ...
Small Business - The Brewton Standard | The Brewton Standard
The Brewton Standard· 4 days agoPatients in the study are treated with the combination of AFM24, Affimed’s innate cell engager (ICE®), and atezolizumab, Roche’s checkpoint inhibitor (CPI ...
From Robust Response to Rapid Resistance
MedPage Today· 3 days agoThe cancer treatment landscape dramatically changed since the first approval of an immune checkpoint inhibitor (ICI), ipilimumab, a CTLA-4 inhibitor, in...
All Over the Map? Mechanisms of ICI Acquired Resistance in NSCLC
MedPage Today· 3 days ago"Resistance is futile." What's less debatable, though, is that patients with non-small cell lung...